deferasirox has been researched along with Anemia With Multinucleated Erythroblasts in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akay, C; Bayhan, T; Çırak, E; Eker, İ; Erdem, O; Gümrük, F; Gürsel, O; Karabulut, E; Ünal, Ş | 1 |
| Buchbinder, D; Hsieh, L; Nugent, D; Puthenveetil, G; Soni, A; Stites, J; Vu, D | 1 |
1 trial(s) available for deferasirox and Anemia With Multinucleated Erythroblasts
| Article | Year |
|---|---|
Heavy metal levels in patients with ineffective erythropoiesis.
Topics: Adolescent; Adult; Anemia, Dyserythropoietic, Congenital; Benzoates; beta-Thalassemia; Child; Child, Preschool; Deferasirox; Erythropoiesis; Female; Humans; Male; Metals, Heavy; Triazoles | 2017 |
1 other study(ies) available for deferasirox and Anemia With Multinucleated Erythroblasts
| Article | Year |
|---|---|
Unrelated hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic anemia and iron overload.
Topics: Anemia, Dyserythropoietic, Congenital; Benzoates; Bone Marrow Transplantation; Child, Preschool; Deferasirox; Deferoxamine; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Iron; Iron Chelating Agents; Iron Overload; Male; Triazoles; Unrelated Donors | 2012 |